(Q43546995)

24 November 2017

title

Effective treatment of hyperhomocysteinemia in heart transplant recipients with and without renal failure (English)

1 reference

24 November 2017

Cook RC

1

1 reference

24 November 2017

Parker S

2

1 reference

24 November 2017

Kingsbury K

3

1 reference

24 November 2017

Frohlich JJ

4

1 reference

24 November 2017

Abel JG

5

1 reference

24 November 2017

Gao M

6

1 reference

24 November 2017

Ignaszewski AP

7

1 reference

24 November 2017

publication date

1 March 2001

1 reference

The Journal of Heart and Lung Transplantation

24 November 2017

published in

1 reference

24 November 2017

volume

20

1 reference

24 November 2017

issue

3

1 reference

24 November 2017

page(s)

310-315

1 reference

Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Homocyst(e)ine and coronary artery disease. Clinical evidence and genetic and metabolic background

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Plasma homocysteine levels and mortality in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Hyperhomocysteinaemia in heart transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Increase in total plasma homocysteine concentration after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Association of mild hyperhomocysteinemia with cardiac graft vascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Treatment of hyperhomocysteinemia in renal transplant recipients. A randomized, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Effect of immunosuppressive therapy, serum creatinine, and time after transplant on plasma total homocysteine in patients following heart transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Hyperhomocysteinemia and Atherosclerotic Vascular Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Homocysteine and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Net uptake of plasma homocysteine by the rat kidney in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

The metabolism of homocysteine: pathways and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

High homocysteine, low folate, and low vitamin B6 concentrations: prevalent risk factors for vascular disease in heart transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

Angiographic trials of lipid-lowering therapy: end of an era?

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

What targets should lipid-modulating therapy achieve to optimise the prevention of coronary heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS1053-2498%2800%2900187-X

7 January 2021

10.1016/S1053-2498(00)00187-X

Identifiers

DOI

1 reference

release_6fsanw3maff27jnswhp5godngi

24 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6fsanw3maff27jnswhp5godngi

24 November 2022

mapped directly with Wikidata item

1 reference